February 2025

A multi-omics approach to delineate the role of neutrophil and plasma indicators in the progression of sepsis and predisposition to early mortality in Severe Alcoholic Hepatitis, SAH Patients. First class post graduate degree including integrated PG degrees

A post graduate degree in any discipline, preferably related to Medical or Allied and Healthcare education or healthcare policy or health administration or public health from any University with outstanding ability and proven administrative capacity and integrity.

A Randomized, Double-blind, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler Relative to Glycopyrronium and Formoterol Fumarate MDI on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Looking for clinical Database Developer experience in eCRF build and edit checks build in Veeva studio; Create eCRF specifications, design, develop and unit test and functionally validate clinical trial setup process. Providing support for the mapping and transformation of clinical data to CDISC SDTM standards. Work independently and accountable for study Data Management deliverables; Coordinate with Biostatistician, Clinical, Medical and local study team as applicable

Responsible for designing overall marketing and communication strategy of brands; Good at Sales & Market data analysis; Must possess knowledge of product strategy, product launch. Torrent Pharmaceuticals announces hiring for a Product Management Team; B.Sc. /B.Pharma plus MBA

B.sc/ B.Pharm/ M.Pharm/ M.Sc; Instrument Analysis HPLC, GC, LCMs, GCMs / Microbiology Testing. Production, QC, Warehouse OSD Formulations

M.Pharmacy / M.Sc. / BPharm; Undertake method development, troubleshooting and method validation to GMP and ICH. Investigation of non-conforming samples, CAPAs, data evaluation and reporting. Write cGMP Quality documents including Standard Operating Procedures, laboratory equipment procedures and investigational protocols.

Galderma today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency and Swissmedic have granted the marketing authorization of nemolizumab for the treatment of both atopic dermatitis and prurigo nodularis in the UK and Switzerland, respectively. Specifically, the approvals are for nemolizumabs subcutaneous use for the treatment of moderate-to-severe atopic dermatitis in combination with topical corticosteroids and/or calcineurin inhibitors

Thousands of single changes in the nucleotides that make up the human genome have been associated with an increased risk of developing cancer. But until now, its not been clear which are directly responsible for the uncontrolled cellular growth that is the hallmark of the disease and which are simply coincidences or minor players.